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LubX is part of the large arsenal of effectors in
Legionella pneumophila that are translocated into
the host cytosol during infection. Despite such
unique features as the presence of two U-box motifs
and its targeting of another effector SidH, the
molecular basis of LubX activity remains poorly un-
derstood. Here we show that the N terminus of
LubX is able to activate an extended number of ubiq-
uitin-conjugating (E2) enzymes including UBE2W,
UBEL6, and all tested members of UBE2D and
UBE2E families. Crystal structures of LubX alone
and in complex with UBE2D2 revealed drasticmolec-
ular diversification between the two U-box domains,
with only the N-terminal U-box retaining E2 recogni-
tion features typical for its eukaryotic counterparts.
Extensive mutagenesis followed by functional
screening in a yeast model system captured func-
tionally important LubX residues including Arg121,
critical for interactions with SidH. Combined, these
data provide a new molecular insight into the func-
tion of this unique pathogenic factor.
INTRODUCTION
Co-evolution of bacterial and eukaryotic cells has led to the
development of sophisticated multi-protein complexes that
enable bacteria to deliver dedicated sets of proteins, called bac-
terial effectors, to the eukaryotic host. Inside the host cell, these
proteins are able to engage a diverse range of eukaryotic targets
to ensure successful infection and immune system regulation.
Among all bacterial pathogens studied to date, Legionella pneu-
mophila, the causative agent of Legionnaires’ disease, maintains
the largest arsenal of effectors, withmore than 300 proteins (Bur-
stein et al., 2009; Huang et al., 2011; Lifshitz et al., 2013; Zhu
et al., 2011) delivered to the host cell via the Dot/Icm type IVB
translocation system (Segal et al., 1998; Vogel et al., 1998).
Distributed throughout its genome, these Dot/Icm translocatedStructure 23, 1459substrates (DITS) represent a potential source of undiscovered
molecular mechanisms that underpin the ability of this bacteria
to colonize a broad spectrum of eukaryotic cell types, which
ranges from human lung macrophages to diverse protozoan
hosts (Fields, 1996).
While DITS and bacterial effectors in general lack well-defined
molecular signatures, there are examples whose function
and activity can be gleaned from resemblance to typically
eukaryote-specific functional domains. Genome analysis of
several pathogenic Legionella strains (Cazalet et al., 2004; de Fe-
lipe et al., 2008; Lurie-Weinberger et al., 2010) has so far yielded
the discovery of 102 eukaryotic-like proteins (ELPs) across a
total of 72 strains. The ELPs identified are diverse and include
both common protein-protein interaction motifs such as ankyrin
repeats, leucine-rich repeats, coiled coils, and domains of spe-
cific functions including F-boxes and U-boxes (Cazalet et al.,
2004; de Felipe et al., 2005, 2008). The presence of the latter
two domains provided the first evidence that several DITS
belong to the growing number of bacterial translocated proteins
that interfere with ubiquitination (for review, see Hubber et al.,
2013).
Ubiquitination is a eukaryote-specific post-translational modi-
fication (for review, see Hershko and Ciechanover, 1998)
mediated by the sequential activity of ubiquitin-activating (E1),
ubiquitin-conjugating (E2) and ubiquitin protein ligase (E3) en-
zymes. Ubiquitin chains on a substrate protein can communicate
several possible signals, largely dependent on the length and
topology of the ubiquitin chain. The most extensively character-
ized of these topologies is the K48-linked poly-ubiquitin chain,
which targets the substrate to the proteasome for degradation.
Target specificity of ubiquitination is largely determined by E3
ubiquitin protein ligases and which have one of several E3
enzyme-specific domains. Single-subunit E3s have at least
one HECT (homologous to E6-associated protein C terminus),
RING (really interesting new gene), or U-box domain that is
responsible for direct interactions with the E2 enzyme. Alterna-
tively, E3s can be part of multi-subunit complexes such as the
SCF (Skp1-Cullin-F-box) complex.
Despite lacking complete ubiquitination machineries, patho-
genic bacteria have developedmany strategies to exploit ubiqui-
tination processes via the translocated proteins that they deliver
to the host cell. Several translocated proteins have been–1469, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1459
identified that mimic the activity of eukaryotic E3 ubiquitin li-
gases (Hicks and Galan, 2010); however, the manner in which
they do so varies widely. In several cases, the pathogenic E3
ubiquitin ligase does not resemble any previously known ubiqui-
tination domains (Singer et al., 2008, 2013; Zhu et al., 2008).
However, a growing number of pathogenic effectors have been
shown to adopt structural folds that are well known as E3
structures. The NleG effectors found in attaching and effacing
pathogens such as enterohemorrhagic Escherichia coli (EHEC)
structurally mimic RING finger/U-box domains despite their
low sequence homology (Wu et al., 2010). Similarly, AvrPtoB a
type III secreted substrate from the tomato pathogen Pseudo-
monas syringae contains a functional U-box that is able to
suppress programmed cell death in both plant and yeast cells
(Abramovitch et al., 2006). L. pneumophila also possesses mul-
tiple methods of manipulation of host cell ubiquitination and has
proteins with U-boxes and a family of F-box-containing proteins,
several of which have been demonstrated to interact with the
host ubiquitination machinery. For example, the F-box proteins
LegU1 and LegAU13 can integrate with mammalian SCF com-
plexes to direct ubiquitination in vitro (Ensminger and Isberg,
2010; Price et al., 2009).
While effectors are generally thought to target host proteins,
the Legionella protein LubX/LegU2 was identified as the first
example of an E3 ligase ‘‘metaeffector,’’ due to its ability to target
another substrate of the Dot/Icm system, SidH (Kubori et al.,
2010). LubX was also reported to target the human host kinase
Clk1 for degradation (Kubori et al., 2008). LubX appears to be
unique in that it contains U-box domains at both its N and
C termini. Using a small panel of eight human E2 enzymes, Ku-
bori et al. (2010) showed that only the N-terminal portion of
LubX is functional in activation of E2 ubiquitin-conjugating
enzymes in vitro, whereas the C-terminal U-box motif was pro-
posed to be involved in substrate interactions, a function not
previously reported for eukaryotic U-box domains. Further un-
derstanding of LubX function as a unique E3 ubiquitin protein
ligase requires characterization of its molecular structure.
Accordingly, we used X-ray crystallography to determine the
structure of individual U-box domains and full-length LubX in
complex with human UBE2D2 E2 enzyme. Informed by these
data, we used a series of genetic and biochemical approaches
to define critical LubX protein surfaces, residues, and other
structural components necessary for E2 activation and metaef-
fector activity against SidH.
RESULTS
Structures and In VitroActivities of LubXU-BoxDomains
Confirm Their Functional Diversity
Residues 1–215 of LubX (Lpp2887) spanning both predicted
U-box domains but lacking the last 25 amino acids containing
the C-terminal translocation signal (Burstein et al., 2009; Huang
et al., 2011; Lifshitz et al., 2013) were purified from E. coli and
prepared for crystallization (see Experimental Procedures for de-
tails). SDS-PAGE and gel filtration demonstrated accumulation
of shorter fragments that corresponded to the approximate
mass of the N- and C-terminal predicted U-box motifs, suggest-
ing that LubX [1–215] is prone to cleavage by endogenous pro-
teases. As such, LubX [1–117] and LubX [102–202] fragments1460 Structure 23, 1459–1469, August 4, 2015 ª2015 Elsevier Ltd Alwere also purified and submitted for crystallization along with a
LubX [1–215] fragment. Crystallization trials for both the N- and
C-terminal fragments resulted in well-diffracting crystals. The
structures of these LubX fragments were solved using seleno-
methionine-enriched protein crystals and the single-wavelength
anomalous dispersion (SAD) phasing method, and refined to
1.95 and 2.88 A˚, respectively (Table 1). Interpretable electron
density in the N- and C-terminal LubX fragment structures
spanned residues 9–117 (Figure 1A) and residues 123–198,
respectively (Figure 1B).
As predicted by primary sequence, the crystal structure of the
N-terminal portion of LubX revealed that residues 31–102 adop-
ted the typical fold of a eukaryotic U-box domain, consisting of a
short a helix (a1, residues 33–35), a central a helix (a2, residues
58–67) set against a turn of a 310 helix (residues 80–82), two short
b strands forming an antiparallel b sheet (residues 47–50 and 55–
57), a C-terminal a helix (a3, residues 87–102), and finally, two
prominent converging loops spanning residues 36–43 (loop 1)
and 70–77 (loop 2). This region of LubX superimposes well with
the U-box domains of eukaryotic ubiquitin ligases (i.e. UBE4B,
PDB: 3L1Z [Benirschke et al., 2010] and CHIP, PDB: 2OXQ [Xu
et al., 2008]) with root-mean-square deviation (RMSD) of 1.1
and 0.92 A˚ over 47 matching Ca atoms, respectively (Figure 1C).
Upstream of the N-terminal U-box domain, residues 11–25 of
LubX formed an a helix (aN) that packed against the C-terminal
a3 helix, forming a platform for the N-terminal U-box domain
(Figure 1A). An extensive survey of the 18 U-box structures in
the PDB (Berman et al., 2000) (corresponding to nine unique
sequences) showed that they lack this additional structural
element.
The crystal structure of the LubX C-terminal fragment (resi-
dues 126–198) also showed structural homology to eukaryotic
U-boxes (Figure 1B). The LubX N- and C-terminal U-box do-
mains superimposed with an RMSD of 1.34 A˚ over 48 Ca atoms,
comprising all secondary structure elements of the U-box folds
except for a3, which is rotated by 10 to the equivalent helix
in the N-terminal U-box (Figure 1C). In accordance with a
previously defined nomenclature (Kubori et al., 2008, 2010),
the N- and C-terminal LubX U-boxes are hereafter be referred
to as U-box 1 and 2, respectively.
Typical of eukaryotic E3 ubiquitin protein ligases, LubX was
previously shown to have in vitro poly-ubiquitination and auto-
ubiquitination activities in the presence of human E1 enzyme
and E2 UBE2D1 (UbcH5a) or UBE2D3 (UbcH5c) enzymes (Ku-
bori et al., 2008, 2010). The Ile39Ala mutation in U-box 1 abro-
gated LubX in vitro ubiquitination activity, while the equivalent
mutation in U-box 2 (Ile134Ala) had no effect, suggesting that
only U-box 1 is involved in interactions with human E2 enzymes
(Kubori et al., 2008). However, only 8 of 37 predicted human E2s
(Michelle et al., 2009) were tested for activity with LubX (Kubori
et al., 2008). Thus, the in vitro ubiquitination activity of the
LubX [1–186] fragment, which contained both U-box domains
(but has better solubility than the full-length protein), was tested
against an expanded panel of 29 human E2 enzymes (Sheng
et al., 2012) representing 13 of the 17 human E2 enzyme families
(Michelle et al., 2009) (the remaining E2s were either not ex-
pressed or insoluble under our standard conditions, see Exper-
imental Procedures for details). The E2 enzymes that triggered
LubX-specific accumulation of ubiquitinated protein speciesl rights reserved
Table 1. Crystallographic Statistics
LubX U-Box 1 LubX U-Box 2 Wild-Type LubX U-Box 2 Ile175Met LubX-FL E2D2 Complex
PDB 4WZ0 4XI1 4WZ2 4WZ3
Data Collection
Space group C2221 P432 P432 P61
a, b, c (A˚) 75.0, 90.4, 40.5 160.23, 160.23, 160.23 160.03, 160.03, 160.03 119.3, 119.3, 49.8
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 120
Resolution (A˚) 50.0–1.95 20.0–2.98 40.0–3.40 40.0–2.70
No. of unique reflections 10,142 13,171 9,956 11,243
Rmerge 0.096 (0.418)
a 0.080 (0.623)b 0.126 (0.649)c 0.054 (0.665)d
I/sI 21.5 (2.94) 23.6 (2.7) 15.0 (2.97) 20.05 (4.07)
Completeness (%) 97.5 (97.3) 88.7 (92.7) 98.6 (100) 99.0 (99.8)
Redundancy 3.7 (3.9) 5.7 (5.6) 6.5 (6.6) 5.0 (5.0)
Refinement
Resolution (A˚) 50.0–1.95 20.0–2.88 40.0–3.41 40.0–2.70
No. of reflections: working, test 9,941, 995 13,167, 659 9,409, 948 10,084, 484
Rwork/Rfree (%) 23.4/27.8 16.2/21.0 17.8/21.6 16.7/22.3
Average B factors
Protein 29.8 75.9 49.8 49.7
Solvent NA 70.5 41.0 NA
Water 43.8 64.8 32.9 38.8
RMSDs
Bond lengths (A˚) 0.009 0.009 0.005 0.005
Bond angles () 1.168 1.050 0.535 0.903
Values in parentheses refer to highest-resolution shell of a1.98–1.95 A˚, b3.03–2.98 A˚, c3.46–3.40 A˚, d2.75–2.70 A˚. NA, no data available.were further tested in the same assay but with LubX fragments
corresponding to U-box 1 (LubX [1–106] or LubX [1–117]) or
U-box 2 (LubX [102–202]) alone. According to our results (Fig-
ure 2A), eight human E2 conjugating enzymes, including the pre-
viously reported UBE2D1 and UBE2D3 and the newly identified
UBE2D2, UBE2D4, UBE2E2, UBE2E3, UBE2W1, and UBE2L6,
were able to support in vitro poly- and auto-ubiquitination activity
of LubX. In each case, U-box 1 was both necessary and suffi-
cient for the formation of poly-ubiquitin protein species, whereas
U-box 2 was either unable to mediate poly-ubiquitination (Fig-
ure 2B) or was not clearly distinguishable from intrinsic E2
auto-ubiquitination activity (as in the case of UBE2S, UBE2R1,
and UBE2R2; Figure S2). Thus, despite their close structural
resemblance, LubX U-boxes 1 and 2 demonstrated drastically
different functional properties, with only U-box 1 acting as an
E3 ubiquitin ligase able to initiate interactions with a defined sub-
set of E2 conjugating enzymes.
Structure of LubX in Complex with the Human
UBE2D2 Ubiquitin-Conjugating Enzyme Defines the
U-Box 1-E2 Interface
LubX in vitro ubiquitination activity was particularly high in com-
bination with the UBE2D2 human E2 enzyme (Figure 2). To reveal
the structural basis for this activity, LubX [1–186] was co-crystal-
lized with UBE2D2 and the complex structure was determined to
2.7 A˚ by the molecular replacement method (Table 1).
The model of the complex of LubX (residues 4–186) and
UBE2D2 (residues 1–147) could be traced in unambiguous elec-
tron density (Figure 3A). In agreement with the isolated U-boxStructure 23, 1459fragment structures, this region of LubX featured two U-box do-
mains connected by the long a helix named aC. Both U-boxes
retained largely the same conformations as in their isolated
structures, except for changes in the conformation of U-box
loops 1 and 2 (not shown). As implied by the model of U-box 1,
the long a3/aC helix in context of this larger LubX fragment
formed a platform against which both U-boxes were arranged.
The position of U-box 2 relative to that of U-box 1 was twisted
90 around the axis of interdomain helix aC, with the loop (res-
idues 120 to 125) connecting U-box 2 with aC helix adopting a
turn conformation. This resulted in U-box 1 and U-box 2 posi-
tioned in a ‘‘front-to-back’’ arrangement, that is, the prominent
converging loops of both U-boxes faced the same direction.
Notably, the kink observed between a3 and aC in the structure
of the isolated U-box 1 was not observed in the LubX [4–186]-
UBE2D2 complex (Figures 1A and 3A), suggesting that this re-
gion may be conformationally mobile.
In full accordance with the LubX in vitro ubiquitination results
(Figure 2), the interaction between LubX and UBE2D2 involves
exclusively U-box 1 domain residues (Figure 3A). The U-box
1-UBE2D2 interface covered 607 A˚2, and involved 18 LubX
and 16 UBE2D2 residues. A comparison of the LubX-UBE2D2
complex structure with the human UBE4B U-box and UBE2D3
complex (PDB: 3L1Z; Benirschke et al., 2010) highlighted signif-
icant similarity between bacterial and eukaryotic U-boxes in
overall shape and location of E2 interaction surfaces. However,
a detailed analysis of LubX interactions with E2 enzyme pointed
to significant deviation in U-box 1 E2-interaction surface com-
pared with equivalent regions in eukaryotic U-box domains–1469, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1461
Figure 1. Structures of LubX U-Box Domains
(A) 1.95-A˚ structure of LubX [9–117] (U-box 1). Residues highlighted in blue belong to the canonical U-box fold.
(B) 2.88-A˚ structure of LubX [123–197] (U-box 2).
(C) Superposition of crystal structures of LubX [9–117] and LubX [123–197], and UBE4B (PDB: 3L1Z).
(D) Sequence alignment and secondary structure assignments of LubX U-box domains. Black and gray shading indicate identical and similar residues,
respectively. Closed circles above alignment refer to LubX residues that form polar contacts or become >80% buried upon contact with UBE2D2. Open circle
above alignment refers to residues important for interaction with SidH.
See also Figure S1.(Figures 3B and 3C; see also structure-based sequence align-
ments in Figure S4). While each of LubX residues contributing
to interactions with UBE2D3 is conserved in subset of human
U-box motifs (Figure S4), the overall composition of the U-box
1 E2-interaction surface appears to be unique to LubX and
is not reproduced in any single human U-box domain. Fur-
thermore, LubX-UBE2D2 interactions feature an expanded
hydrogen bond network including three additional interactions
between respective LubX-UBE2D3 residues Ile39-Arg5, Lys68-
Ser91, and Arg75-Glu92, which do not have equivalents in
structurally characterized human E2-U-box complexes such as
UBE4B-UBE2D3.
With no evidence that U-box 2 can participate in E2 engage-
ment, the specific structural compositions of the two U-boxes
were examined for features that may explain this functional
distinction. Of the 18 U-box 1 residues involved in interactions
with UBE2D2, 15 showed non-conservative substitutions at the
equivalent positions in U-box 2. In particular, the three U-box
residues known to be critical for interactions with E2 and present
in LubX U-box 1 (residues Ile39, Trp64, Pro72) are only partially
conserved in U-box 2 (equivalent residues Ile134, Phe159,
Asp167) (Figures 1D and 3D). The presence of Lys136 in U-box
2, which is structurally equivalent to Ser41 in U-box 1 (Figures
3B and 3D), may also prevent E2 association, significantly
changing the physiochemical properties of the surface signifi-
cantly and physically obscuring Ile134, which might otherwise
fulfill its typical role in E3-E2 interactions in associating with a1
of the E2. These data show that although the U-box fold has1462 Structure 23, 1459–1469, August 4, 2015 ª2015 Elsevier Ltd Albeen closely conserved, U-box 2 has significantly diverged
from U-box 1 in residue composition throughout the solvent-
exposed surface that formed the canonical E2 binding site in
most U-boxes. These structural differences are consistent with
the observed functional divergence between LubX U-box motifs
and of the loss of E2-interaction capacity by U-box 2.
SidH Is the Primary Target for LubX in Legionella
Proteome
The diverse nature of the two known LubX targets SidH and host
kinase Clk1 (Kubori et al., 2008, 2010) and the large number
(>300) of DITS present in Legionella raised the possibility of
LubX targeting multiple proteins, particularly among other
DITS. To investigate this possibility, an unbiased screen for
LubX targets within the Legionella proteome was performed us-
ing affinity purification coupled with mass spectrometry (AP-
MS). To assess the repertoire of DITS expressed at each of
these growth stages, the proteome of L. pneumophila strain Phil-
adelphia-1 grown to exponential and post-exponential phase
was profiled using high-resolution accurate mass spectrometry
(see Supplemental Experimental Procedures). Details of all
proteins identified in each growth phase are summarized in
Table S1.
Between both Legionella proteome samples, 1,498 of 2,942
possible proteins were identified at a false discovery rate of
1%, with 599 proteins detected in both growth stages. Among
known Legionella DITS proteins, 77 and 99 were identified in
exponential and post-exponential phases, respectively, withl rights reserved
Figure 2. Auto-Ubiquitination of LubX Is
Dependent on U-Box 1
(A) LubX [1–186] was tested for its ability to facili-
tate the formation of poly-ubiquitin chains in the
presence of E1, ubiquitin, ATP, and 29 different
E2s. Ubiquitination activity was determined by
SDS-PAGE and western blot analysis using anti-
ubiquitin antibodies. Asterisks denote reactions
with activity not attributable to E2 auto-ubiquiti-
nation (see Figure S2).
(B) Representative auto-ubiquitination reactions
for UBE2D2, UBE2E3, UBE2W, and UBE2L6 with
LubX [1–186] as well as U-box 1 and 2 domain
fragments. Only LubX fragments containing U-box
1 exhibited auto-ubiquitination activity.
See also Figure S2.only 32 DITS detected in both phases. Thus, combined expo-
nential and post-exponential axenic grown Legionella lysates
contained readily detectable amounts of close to half of the full
DITS arsenal known for this bacterium. Based on this observa-
tion, a combined sample composed of equal amounts of expo-
nential and post-exponential grown Legionella-clarified cell
lysates was probed for potential LubX targets. Streptavidin-
binding peptide (Keefe et al., 2001) tagged LubX [1–221]
(Lpg2830) was used as a bait, and proteins co-purified by
streptavidin-based affinity were analyzed by mass spectrom-
etry. SidH was the only DITS that co-precipitated with LubX
(Table 2), confirming the highly specific nature of the interactions
between these two proteins and suggesting that SidH is the
primary interaction partner for LubX in the Legionella proteome
under our experimental conditions. These experiments were
also repeated with a LubX I45A, R121A, and R121E mutants as
outlined next.
Functional Mapping of the LubX-SidH Interaction
Interface
Empowered by this structural information, we set out to charac-
terize the molecular basis of LubX interactions with SidH. For
this, we established an in vivo functional screen using the
budding yeast Saccharomyces cerevisiae. A previous study, in
which individual DITS were expressed in S. cerevisiae, found
that overexpression of SidH resulted in severe growth arrest
(Heidtman et al., 2009). Based on the evidence that LubX ubiqui-
tinates SidH leading to its degradation (Kubori et al., 2010), we
predicted that co-expression of LubX and SidH would alleviate
the toxic effect of SidH on yeast. Indeed, yeast cells co-overex-
pressing LubX and SidH demonstrated normal growth compara-
ble with the control culture containing empty expression vector
(Figure 4A). Notably, individual overexpression of neither LubX
U-box 1 nor U-box 2 fragments was able to rescue SidH toxicity.Structure 23, 1459–1469, August 4, 2015To identify whether LubX surface-
exposed residues are essential for the
interaction with SidH, we prepared 65
LubX variants, each carrying individual
residue mutations of 59 unique surface-
exposed positions throughout the struc-
ture of LubX (Figure 3A), and tested the
ability of these variants to alleviate SidHtoxicity to yeast. For this, haploid yeast strains carrying individual
LubX mutant were mated with a haploid yeast strain carrying a
SidH-overexpressing plasmid or empty vector. The resulting
diploid strains carrying both plasmids were selected by pinning
onto medium selective for both plasmids and subsequently
pinned onto protein expression-inducing medium. To quantify
the growth of each resulting strain, the spot (pinned in quadrupli-
cate) sizes of each diploid strain were measured and compared
with the spot size of strains containing the empty vector control
or wild-type LubX (Figure 4B).
According to this analysis, LubX variants carrying I45A, S47D,
W70A, or Q79F mutations were not able to rescue SidH-medi-
ated toxicity (Figures 4B and 4D). These four residues localize
to the LubX E2 interaction surface of U-box 1, suggesting that
the observed effect is due to interruption of LubX-E2 interac-
tions. In line with these observations, the substitution to alanine
of the conserved isoleucine residue (Ile45 in Lpg2830 and Ile39 in
Lpp2887) at this surface was previously shown to result in com-
plete loss of in vitro E3 ligase activity of LubX (Kubori et al., 2008)
and several eukaryotic U-box E3 ligases (Andersen et al., 2004;
Ohi et al., 2003). Unexpectedly, of the remaining 61 LubX vari-
ants carrying single mutations of surface-exposed residues,
only the R121E variant was defective in its ability to rescue
SidH toxicity. The Arg121 residue localizes to the C terminus of
the aC helix connecting the two U-box domains (Figure 4D).
Interestingly, LubX variants carrying individual substitutions of
nearby residues, including Q118E, N119D, R125A/E, E189A,
Q192E, and Q193E, all retained the ability to rescue SidH
toxicity. Furthermore, none of the mutations at the canonical
E2 binding surface of U-box 2 (residues 140–143, 146, 147,
159–160, 164–165, and 167) had any detectable effect on
LubX activity against SidH, suggesting that these residues may
not play a critical role in LubX-SidH interactions. Furthermore,
we tested these newly discovered mutations for their ability toª2015 Elsevier Ltd All rights reserved 1463
Figure 3. Structure of LubX-UBE2D2
Complex
(A) Overall architecture of LubX-UBE2D2 complex.
LubX U-box 1 and 2 are colored blue and red,
respectively, and UBE2D2 is green.
(B–D) Detailed comparison of U-box-E2 in-
teractions. (B) LubX U-box 1-UBED2. (C) UBE4B-
UBE2D3 (PDB: 3LIZ). (D) LubX U-box 2. Residues
shown are those that form hydrogen bonds
(dashed black line) or become >80% buried in the
U-box-E2 interaction.
See also Figure S4.bind to SidH by using the streptavidin-binding peptide tagged
LubX variants carrying R121E or R121A substitutions. Thesemu-
tants lost their ability to co-precipitate SidH from Legionella
lysate when used as bait in the AP-MS experiment similar to
the one described above (Table 2), despite still demonstrating
robust in vitro ubiquitination activity in the presence of human
E1 and UBE2D2 enzymes (Figure S3), consistent with them con-
taining intact U-box 1 domains. This analysis suggests that the
interactions between LubX and SidH are dissimilar from those
characterized for canonical U-boxes and E2 ubiquitin-conju-
gating enzymes and involves at least one LubX residue outside
of the U-box 2 domain, which has no known structural equivalent
in its eukaryotic counterparts.
DISCUSSION
The L. pneumophila translocated protein LubX mimics the func-
tion of a eukaryotic E3 ubiquitin ligase to specifically target
another translocated protein, SidH, for degradation by the host
proteasome (Kubori et al., 2008, 2010). Here, we present the
crystal structures of both the N- and C-terminal domains of
LubX, which confirmed the presence of two distinct yet struc-
turally similar domains reminiscent of eukaryotic U-boxes.
Screening of LubX and its individual U-box domains against a
panel of 29 ubiquitin-conjugating E2 enzymes, representing 13
out of 17 3 102 groups encoded by the human genome,1464 Structure 23, 1459–1469, August 4, 2015 ª2015 Elsevier Ltd All rights reservedconfirmed the ability of LubX U-box 1 to
engage a defined subset of these en-
zymes for the formation of poly-ubiquitin
protein species. In addition to the previ-
ously identified UBE2D1 and UBE2D3 E2
enzymes, we demonstrated that LubX
U-box 1 is able to interact with UBE2D2
as well as the UBE2E family members
and both UBE2WandUBE2L6 E2s. Unlike
the UBE2D and UBE2E family enzymes,
which are closely related in sequence,
UBE2W and UBE2L6 stand out as having
only 30%–40% identity to UBE2D and
UBE2E family members. These new data
show that LubX is able to engage a
significantly larger arsenal of host E2 en-
zymes than previously established, and
raises the possibility of this pathogenic
E3 ligase having additional as yet uniden-tified functions involving the diverse E2 enzymes identified in
this study.
Characterization of a more comprehensive set of E2s able to
support LubX activity also highlighted molecular features that
may be responsible for LubX specificity for this particular subset
of E2 enzymes. Our data show that UBE2L3, or UBE2Q1 and Q2
E2 enzymes, are not able to support in vitro ubiquitination activity
of LubX despite their close similarity to UBE2L6 and UBE2W en-
zymes, respectively. Inability of UBE2L3 to support LubX activity
is probably due to this E2 enzyme being HECT and RBR (RING-
between-RING) E3 specific (Wenzel et al., 2011). In the case of
UBE2Q1 and Q2 E2 enzymes, one possible explanation is that
UBE2Q E2s feature an Asp residue (PDB: 1ZUO; Sheng et al.,
2012) at the position equivalent to Lys4 in UBE2D2 and
UBE2W. This substitution would position this acidic residue in
proximity to the hydrophobic patch of LubX around residue
Ile39, which is critical for E2 interaction, potentially causing sur-
face charge clashes and disrupting the formation of the Ile39-
Arg5 hydrogen bond. The presence of Gly in UBE2Q1 and Q2
at the position equivalent to UBE2D2 Glu92 may also signifi-
cantly reduce the ability of LubX to interact with these E2
enzymes.
The structure of LubX in complex with the human UBE2D2 E2
enzyme highlighted the role of the U-box 1 domain as the exclu-
sive E2-interacting module within LubX. In addition, it revealed
that the LubX-E2 interface involves conserved UBE2D2 residues
Table 2. Affinity Purification-Mass Spectrometry with L. pneumophila Lysate Identifies SidH as the Only Strong Candidate Interactor
for LubX
ID
LubX [1–221] LubX [1–221].I45A LubX [1–221].R121A LubX [1–221].R121E
Total Peptides Total Peptides Total Peptides Total Peptides
Rep A Rep B Rep A Rep B Rep A Rep B Rep A Rep B
LubX 514 328 475 399 390 310 558 334
SidH 260 178 166 192
NusA 51 41 33 20
RpsE 9 14
SBP-tagged LubX was immobilized to magnetic Sepharose-streptavidin beads and incubated with a 1:1 mixture of exponential and post-exponential
lysates of L. pneumophila. Putative binding proteins were eluted with biotin and identified by mass spectrometry. Non-LubX-specific background in-
teractions were filtered out on the basis of GPM/X!Tandem expected score <50, <2 unique peptides, between-replicate inconsistencies, or their
appearance in the analyses of other SBP-tagged DITS proteins in similar or greater numbers. SidH was the only DITS identified as a specific interactor
of LubX. Proteins NusA and RpoA are not translocated proteins and are therefore believed to be non-specific contaminants. See also Figure S3 and
Table S1.that are also critical for the interaction of this E2 enzyme with eu-
karyotic U-box domains. Specifically, the UBE2D2 residues
Lys8, Phe62, and Pro95 located at the LubX interacting surface
are conserved among all human E2 enzymes that are active with
this E3. Pro95 of the Ser-Pro-Ala motif is an important determi-
nant of specificity between human E2 enzymes and the eukary-
otic U-box CHIP E3 (Soss et al., 2011; Xu et al., 2008). Notably,
LubX and CHIP show similar profiles of E2 enzymes able to sup-
port their activity in vitro, all of which, except for UBE2L6, harbor
the requisite Ser-Pro-Ala motif required for binding. The ability to
engage this latter E2, which features a Lys-Pro-Cys instead of
the Ser-Pro-Ala motif, indicates that LubX only partially relies
on the latter motif in interactions with host E2 enzymes. Exami-
nation of the remainder of the LubX-E2 interface residues that
play a significant role in the interaction with UBE2D2 shows
that although LubX shares little similarity to any single known
U-box domain, residues involved in the interaction can typically
be found elsewhere in one ormore eukaryotic U-boxes, suggest-
ing that LubX may be optimized to interact with a broad range of
host E2s.
Structural characterization of the LubX-UBE2D2 complex also
highlighted significant differences between the U-box 1 and 2
domains. While the LubX U-box 2 domain follows the general
architecture of the U-box fold, there are significant changes in
the biochemical makeup of its ‘‘E2 interaction’’ surface as well
as more subtle structural differences including different confor-
mations of the two key loops. Conformational changes in
U-box 2 loop 1 and loop 2 in comparison with equivalent regions
of U-box 1 may place residues of U-box 2 away from an orienta-
tion consistent with E2 binding.
The divergence of the LubX C-terminal domain from canonical
U-box function was further emphasized by its role in interactions
with SidH. Using a yeast-based assay that leverages the toxicity
of heterologously expressed SidH and the ability for LubX co-
expression to alleviate this toxicity, we sought to better under-
stand the nature and location of the LubX-SidH interaction.While
the integrity of C-terminal domain encompassing U-box 2
domain was necessary for LubX function against SidH, extensive
mutagenesis guided by the crystal structure of the LubX2-
UBE2D2 complex revealed no evidence to support the direct
involvement of U-box 2 in SidH recognition. Furthermore, the
single residue that appears to be critical for LubX-SidH interac-Structure 23, 1459tions, Arg121, localized to the end of the aC helix and is not
part of the U-box fold. In addition, we verified the importance
of this position for the physical interaction with SidH, by testing
the abilities of wild-type and I45A, R121A, or R121E variants of
LubX for their ability to co-precipitate the SidH from crude
Legionella lysate. As expected, wild-type LubX and LubX I45A
co-precipitated SidH whereas R121A and R121E mutants
(both of which were verified to be active as E3 ligases) did not.
Notably, a LubX C-terminal fragment encompassing the U-box
2 motif that was previously reported (Kubori et al., 2010) to be
required for binding to SidH also contained the sequence corre-
sponding to aC helix, and thus included the Arg121. Given the
significant size of SidH (253 kDa), it is likely that LubX-SidH
interaction occurs over a large area with a number of residues
contributing to the interaction. Thus, the lack of LubX variants
deficient in SidH interactions other than R121E LubX may be
due to our single-point mutation-focused analysis being inade-
quate to disrupt a potential large surface area of LubX-SidH
interaction. Superimposition of our structures covering U-box 2
reveals that R121 may be well positioned to stabilize the
observed conformation of LubX, providing a possible explana-
tion for the apparent singular importance of this residue. Interest-
ingly, when we model ubiquitin onto our co-crystal structure,
non-covalently ‘‘backside bound’’ ubiquitin that has been shown
to greatly increase activation of ubiquitin transfer (Buetow et al.,
2015) is able to fit neatly into the space between UBE2D2 and
U-box 2 (data not shown), suggesting a new potential function
for U-box 2.
Our unbiased search of the L. pneumophila str. Philadelphia-1
proteome identified SidH as the primary target of LubX; however,
the possibility for functional interactions between LubX and other
effectors not present in our lysatemix or that bindweakly to LubX
remains. While the function of SidH during Legionella infection
remains unknown, both our own and previously published data
(Kubori et al., 2010) clearly show that SidH function requires
tight regulation by LubX. In line with this observation, the expres-
sion of SidH in our yeast model eukaryotic system led to com-
plete growth arrest that was alleviated by co-expression of
LubX. These data, combined with the observation that many
DITS exhibit a toxic phenotype similar to SidH when expressed
in yeast (Heidtman et al., 2009), raise the possibility that
L. pneumophila may be required to conduct self-regulation of–1469, August 4, 2015 ª2015 Elsevier Ltd All rights reserved 1465
Figure 4. In Vivo Screening of LubX Reveals
Domains and Residues Essential for Effec-
tual Rescue of SidH Toxicity
(A) Spot dilutions of S. cerevisiae co-expressing
SidH (lpg2829) and LubX (lpg2830), LubX U-box 1,
U-box 1 plus aC helix, or U-box 2 indicate that full-
length LubX alleviates the toxicity of SidH. Rescue
of SidH toxicity was not observed when using
U-box 1, U-box 1 plus aC helix, or U-box 2
domains.
(B) Individual strains carrying SidH and LubX or a
LubX mutant were arrayed in quadruplicate. Two
strains (‘‘isolate 1’’ and ‘‘isolate 2’’) of each mutant
were assayed per plate.
(C) Expression of mutant LubX strains with a sig-
nificant reduction in ability to rescue SidH was
validated by western blot.
(D) Plate images were processed using SGAtools
to obtain spot sizes. The graph shows data for one
of the isolates. Mutations with a significant defect
in their ability to rescue SidH are highlighted in
bold. Error bars show the standard deviation for
this isolate.
(E) The positions of LubX mutants with a significant
reduction in their ability to rescue SidH are indi-
cated on the LubX-UBE2D2 complex structure.
See also Table S2.its DITS functions in several other cases, and that this require-
ment may be more frequent than previously thought. With
more than 300 DITS, further studies into the prevalence of
DITS metaeffector activities are warranted. Understanding the
dynamics of complex bacterial-host interactions such as those
employed by Legionella will be critical to our detailed under-
standing of microbial disease.EXPERIMENTAL PROCEDURES
Protein Purification
LubX orthologs from L. pneumophila str. Paris and L. pneumophila str.
Philadelphia (UniProt: Q5X159/Lpp2887 and UniProt: Q5ZRQ0/Lpg2830,
respectively) were cloned into either pET28-SBP-TEV (for proteins requiring
SBP-tag) or p19MBP-L (no SBP-tag) as required, Human E2 expression con-
structs were obtained in pET28 (Sheng et al., 2012). BL21 (RIL) DE3 E. coli
cultures were grown in LB or Studier media (without galactose) supple-
mented with the appropriate antibiotics, and expression was induced with
0.4 mM isopropyl-b-D-1-thiogalactopyranoside. Cultures were harvested
by centrifugation and pellets lysed by sonication on ice in 50 mM HEPES
(pH 7.5), 150 mM NaCl, and 1 mM PMSF. All further purification was con-
ducted at 4C. Lysate was clarified by ultracentrifugation at 17,000 3 g for
30 min, and to this, 1–5 ml of Ni-NTA resin (Qiagen) was added and incu-
bated with gentle rotation for 30 min. Resin was washed with 50 mM HEPES
(pH 7.5), 150 mM NaCl, and 30 mM imidazole, and protein eluted with 50 mM
HEPES (pH 7.5), 150 mM NaCl, and 500 mM imidazole. Proteins were further1466 Structure 23, 1459–1469, August 4, 2015 ª2015 Elsevier Ltd All rights reservedconcentrated using a centrifugal concentrator,
flash-frozen in liquid N2, and stored at 80C.
Crystallization and Structure
Determination
Crystals of selenomethionine-substituted (SelMet)
LubX [1–186], native LubX U-box 2, SelMet LubX
U-box 2 mutant Ile175Met, and SelMet LubX in
complex with E2D2.C85S-Ub conjugate were
grown at 23C using hanging-drop vapor diffusion
with the following protein concentrations plus reservoir solutions: 30 mg/ml
protein plus 0.25 M ammonium sulfate, 0.1 M imidazole (pH 7.8) and 28%
PEG8K; 15mg/ml protein and V8 protease (1:100molar ratio protease/protein)
plus 1.6 M ammonium sulfate, 0.1 M HEPES (pH 7.5), and 2% hexanediol;
15 mg/ml protein, 1.6 M ammonium sulfate, 0.1 M HEPES (pH 7.5), and 2%
hexanediol; 15 mg/ml E2D2.(C85S)-Ub conjugate and an equimolar concen-
tration of LubX, plus 0.2 M sodium tartrate, 0.1 M Tris-HCl (pH 8.5), and
25% PEG3350. Crystals were cryoprotected with reservoir solution supple-
mented with 20% glycerol except for LubX U-box 2 mutant Ile175Met, which
was also supplemented with sodium chloride. SDS-PAGE of LubX [1–186]
indicated degradation of the protein, and residues 9–117 were identified in
the electron density.
Diffraction data were collected at 100 K at beamline 19-ID at the Structural
Biology Center, Advanced Photon Source at wavelength 0.9794 A˚ (selenium
peak) and reduced with HKL-3000 (Minor et al., 2006). LubX U-box 1 structure
was solved first by SAD phasing using PHENIX.solve (Adams et al., 2010),
which identified one SelMet site (residue 34), followed by model building by
PHENIX.autobuild. The structure of LubX-U-box 2 Ile175Met was determined
by SAD phasing using PHENIX.solve, which identified three SelMet sites, fol-
lowed by model building by PHENIX.autobuild. This model of LubX U-box 2
Ile175Met was used to determine the structure of native LubX U-box 2; model
refinement was focused on this fragment due to its higher resolution. Structure
of LubXU-box 1-UBE2D2 complexwas determined bymolecular replacement
using as search models the structure of UBE2D2 from PDB: 4DDI (Juang et al.,
2012) and the structure of LubX U-box 1, using PHENIX.phaser. All structures
were refined using PHENIX.refine. The final models include the following res-
idues: LubX U-box 1 = 9–117; LubX U-box 2 (wild-type) = 123–198; LubX
U-box 2 (Ile175Met) = 124–198; LubX U-box 1-UBE2D2 complex = 4–186 of
LubX and 1–147 of E2D2 plus N-terminal Gly residue from the expression tag.
All B factors were refined as isotropic. All geometries were verified with
PHENIX.refine and the RCSB PDB Validation server. Structure coordinates
were deposited in the PDB under accession codes PDB: 4WZ0, 4WZ1,
4WZ2, 4WZ3 for the LubX U-box 1, LubX U-box 2 (wild-type), LubX U-box 2
(Ile175 mutant), and LubX-UBE2D2 complex structures, respectively.
Structure Analysis
Protein-protein interfaces were analyzed using PDBePISA (http://www.ebi.ac.
uk/pdbe/prot_int/pistart.html) (Krissinel and Henrick, 2007). For comparison of
U-boxes, U-box 1 and U-box 2 were superposed based on the core central a
helix, 310 helix, and b sheets. Definitions for U-box boundaries were from
PFAM PF04564 and publications for PDB: 3L1Z (Benirschke et al., 2010),
PDB: 2C2V (Zhang et al., 2005), PDB: 2OXQ (Xu et al., 2008).
Ubiquitination Assays
Ubiquitination reactions were performed as described previously (Singer et al.,
2008). In brief, 4 mg of ubiquitin, 0.13 mg of E1, and 2 mg of E2 were incubated
together with 2 mg of the specified fragment of LubX in 20 ml of reaction buffer
(50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 10 mM ATP, 10 mM MgCl2, 0.5 mM
DTT) at 25C for the time specified. Reactions were terminated by the addition
of an equal volume of 23 Laemmli sample buffer (0.125 M Tris-HCl [pH 6.8],
20% [v/v] glycerol, 4% [w/v] SDS, 100 mM DTT, 0.004% [w/v] bromophenol
blue). Reaction mixtures were separated by SDS-PAGE, transferred to nitro-
cellulose, and probed with a-ubiquitin antibody (Millipore MAB1510).
L. pneumophila Culture
An L. pneumophila str. Philadelphia-1 derived (Lp03) strain (Berger and Isberg,
1993; Rao et al., 2013) was patched on charcoal-N-(2-acetamido)-2-aminoe-
thanesulfonic acid (ACES)-yeast extract-thymidine plates, and used to inocu-
late overnight 37C cultures in ACES-yeast extract-thymidine broth (Berger
and Isberg, 1993). Cultures were grown to either exponential phase (OD600 =
1.6) or post-exponential phase (cessation of growth, increase in pigmentation,
and an increase in motility as visualized by light microscopy). Cells were har-
vested by centrifugation at 4C, 5,000 3 g for 10 min.
AP-MS
Exponential and post-exponential Legionella cell pellets were resuspended in
ice-cold lysis/binding buffer (50 mM HEPES [pH 8.0], 150 mM NaCl, 5 mM
DTT, 5 mM EDTA, 13 complete mini EDTA-free protease inhibitor cocktail
[Roche]) at 1 3 109 cells/ml and sonicated on ice. Lysates were clarified by
centrifugation at 21,000 3 g for 10 min and stored at 80C until needed.
50 ml of Streptavidin Mag Sepharose beads bearing 6xHis-SBP baits were
added to 1ml of lysate depleted of excess endogenous biotin with streptavidin
agarose, and incubated with gentle agitation for 3 hr. Beads were washed
twice with binding buffer and transferred to a fresh tube during a final wash
step. Bait and bound proteins were eluted using 100 ml of 100 mM ammonium
bicarbonate (pH 8.5) and 2.5 mM biotin. 1 mg of sequencing grade modified
trypsin (Promega) was added to samples and incubated overnight at 37C.
Digestion was terminated by addition of trifluoroacetic acid to a final concen-
tration of 0.5%, and samples were further processed usingOMIXC18 tips (Agi-
lent) according to the manufacturer’s instructions. Peptides were eluted with
95% acetonitrile and 0.1% formic acid, and dried to completion by vacuum
centrifugation. Samples were resuspended in 0.1% formic acid and analyzed
by mass spectrometry on an LTQ XL mass spectrometer. Peptide identifica-
tions were performed using GPM/X!Tandem. See Supplemental Experimental
Procedures for details.
In Vivo Yeast Screening
Spot Dilutions
The ability of LubX, LubX U-box 1, U-box 1 plus aC, and U-box 2 to rescue
toxicity of SidH expression in yeast was assayed by spot dilution. BY4742
(MATa his3D1 leu2D0 met15D0 ura3D0) (Brachmann et al., 1998) was co-
transformed with plasmids carrying sidH (lpg2829) Gateway cloned into
pAG423-GAL-HA-ccdB and either lubX (lpg2830), one of its fragments in
pYES2 NT/A, or empty vector pYES2 NT/A. Overnight cultures of each strain
were grown in SD-uracil histidine and 2% glucose, and subsequently diluted
to OD600 of 1.0, 0.2, 0.04, and 0.008, then spotted onto both SD-histidineStructure 23, 1459and uracil + 2% galactose plates using the VP 407 AH pin tool (V&P Scientific)
and grown for 2 days at 30C.
In Vivo Mutational Characterization of LubX-SidH Interaction
Characterization of the LubX-SidH interaction interface was performed using a
high-density (1,536) pinning assay, similar to the synthetic genetic array proce-
dure (Tong and Boone, 2006) with modifications (see Table S2 and Supple-
mental Experimental Procedures for full details and description of this
procedure). In briefly, haploid S. cerevisiae strains BY4741 (MATa his3D1
leu2D0 lys2D0 ura3D0) and BY4742 (Brachmann et al., 1998) carrying galac-
tose-inducible pAG423GAL-HA-sidH (lpg2829) or empty vector control, and
pYES2 NT/A lubX (lpg2830), lubX mutants or empty vector control, respec-
tively, were mated. Resulting diploid strains carrying both plasmids were
grown on SD-histidine and uracil + 2% galactose plates, imaged, and quanti-
fied using SGAtools (Wagih et al., 2013) (http://sgatools.ccbr.utoronto.ca/).
LubX mutants that failed to rescue the yeast toxicity of SidH were re-
sequenced to confirm the identity of the mutations. Western blots were per-
formed using a-Xpress antibodies (Life Technologies) to verify that the LubX
mutants were expressed and stable.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2015.05.020.
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